Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues

Bruce J. Trock; R. Jeffrey Karnes

首页> 外文期刊>European urology >Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues

【24h】

Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues

机译：回复Erfan Ayubi和Saeid Safiri给编辑的信Re：R. Jeffrey Karnes，Voleak Choeurng，Ashley E. Ross等。验证基因组风险分类器，以预测具有不良病理特征的男性前列腺癌特异性死亡率。 EUR UROL。在新闻。 https://doi.org/10.1016/j.eururo.2017.03.036。方法论问题

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2017年第6期|共2页
作者
Bruce J. Trock; R. Jeffrey Karnes;
展开▼
作者单位

James Buchanan Brady Urological Institute and Department of Urology Johns Hopkins School of;

Department of Urology Mayo Clinic;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献

1. Reply to Erfan Ayubi and Saeid Safiri's Letter to the Editor re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036. Methodological Issues [J] . Bruce J. Trock, R. Jeffrey Karnes European urology . 2017,第6期

机译：回复Erfan Ayubi和Saeid Safiri给编辑的信Re：R. Jeffrey Karnes，Voleak Choeurng，Ashley E. Ross等。验证基因组风险分类器，以预测具有不良病理特征的男性前列腺癌特异性死亡率。 EUR UROL。在新闻。 https://doi.org/10.1016/j.eururo.2017.03.036。方法论问题
2. Re: R. Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, et al. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2017.03.036 [J] . Erfan Ayubi, Saeid Safiri European urology . 2017,第6期

机译：Re：R. Jeffrey Karnes，Voleak Choeurng，Ashley E. Ross等。验证基因组风险分类器，以预测具有不良病理特征的男性前列腺癌特异性死亡率。 EUR UROL。在新闻。 https://doi.org/10.1016/j.eururo.2017.03.036
3. Reply to Gopa Iyer, Bernard H. Bochner, Eliezer M. Van Allen, David B. Solit, and Jonathan E. Rosenberg's Letter to the Editor re: Russell EN Becker, Alexa R. Meyer, Aaron Brant, et al. Clinical Restaging and Tumor Sequencing are Inaccurate Indicators of Response to Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.07.016 [J] . Becker Russell E. N., Baras Alex, Bivalacqua Trinity J. European urology . 2021,第2期

机译：回复Gopa Iyer，Bernard H. Bochner，Eliezer M. Van Allen，David B. Solit和Jonathan E. Rosenberg的信Re：Russell En Becker，Alexa R. Meyer，Aaron Brant等人。临床恢复和肿瘤测序是对肌肉侵入性膀胱癌的新辅助化疗的反应不准确的指标。 EUR UROL。在新闻。 https://doi.org/10.1016/j.eururo.2020.07.016
4. Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features [O] . Robert Jeffrey Karnes, Voleak Choeurng, Ashley E. Ross, -1

机译：验证基因组风险分类器以预测具有不利病理特征的男性的前列腺癌特异性死亡率

著录项

相似文献

相关主题

期刊订阅